Remote Monitored Systems PLC Update on Pharm to Farm Ltd (1015R)
March 04 2021 - 2:00AM
UK Regulatory
TIDMRMS
RNS Number : 1015R
Remote Monitored Systems PLC
04 March 2021
4 March 2021
The information contained within this announcement is deemed by
the Company to constitute inside information stipulated under the
Market Abuse Regulation (EU) No. 596/2014. Upon the publication of
this announcement via the Regulatory Information Service, this
inside information is now considered to be in the public
domain.
Remote Monitored Systems plc
("RMS" or the "Company")
Update on Pharm to Farm Ltd ("P2F")
The Company is pleased to report the significant progress
achieved since the announcement on 18 February.
-- Order for 1.0 million of P2F's masks placed with Volz with
outsourcing manufacturing discussions in progress
-- Distribution agreement to make masks available in UK & Europe via Amazon
-- Launch of web site for the P2F mask
-- Independent adviser and line manager appointed to bring mask machine into full operation
Further to previous announcements in relation to discussions the
Company has held with the Volz Group of Companies ("Volz"), an
initial order has been placed for one million of P2F's masks,
incorporating P2F's proprietary antiviral material
(<ALPHA>-virion), and discussions are under way to extend
this into a production outsourcing arrangement to increase the
supply of the anti-viral masks. Not only should this approach
enable the expected demand for the mask to be met but it will also
allow P2F to focus on its core strengths of developing and
producing nanomaterials and associated innovative products.
Whilst interest in the masks has been strong, it was important
to ensure that potential supply issues had been resolved before
committing to deliveries. On the back of the discussions with Volz,
P2F has entered into a distribution agreement with Francis McIntyre
Limited, an online garment retailer with the brand FM London,
("Francis McIntyre") to make P2F's masks available to customers
across the UK and Europe via the Amazon E-commerce platform
("Amazon"). Under the terms of the agreement, Francis McIntyre has
placed an initial order for 100,000 masks, with the exclusive right
to sell via Amazon being conditional upon Francis McIntyre ordering
a minimum of 1 million masks per month. P2F has also started
supplying batches of between 5,000 and 10,000 masks to a number of
customers looking to trial the product ahead of potentially placing
larger orders in the future. A dedicated website for the mask has
been created (www.pro-larva.com) and is expected to go live by the
end of this week, which should help drive further demand.
P2F is in discussions with Lemu Group, the manufacturer of the
mask making machine, regarding mechanical issues that need to be
resolved before the machine at BioCity can be considered to be
fully commissioned. The Company has agreed to appoint Egremont
Capital Limited ("Egremont") as an independent advisor for the next
three months to assist with development of P2F's production
capabilities. Jonathan Hall, Egremont's founder, has a background
in production manufacturing, in addition to Egremont's expertise as
a corporate advisor. In addition to a monthly fee, Egremont may be
issued with up to 500,000 new ordinary shares dependent on
achieving certain production milestones. In addition, a line
manager has been recruited at BioCity to strengthen the production
team.
Antony Legge, Executive Chairman of RMS, said; "We are very
pleased to update the market with the positive developments
achieved by the P2F team. Whilst a number of issues remain with the
machine at BioCity, the purchase order with Volz coupled with the
intentions by both parties to enter into a more formal outsourced
manufacturing agreement, means P2F can commence sales with
confidence as we anticipate a continuing market need for P2F's
proprietary <ALPHA>-virion material, notwithstanding the
progress of various national Covid-19 vaccination programmes."
- ENDS -
ENQUIRIES :
Remote Monitored Systems plc
Antony Legge (Executive Chairman) via IFC Advisory
SP Angel Corporate Finance LLP +44 20 3470 0470
Nominated Adviser and Joint Broker
Stuart Gledhill
Caroline Rowe
Peterhouse Capital Limited +44 20 7469 0930
Joint Broker
Lucy Williams
IFC Advisory Ltd
+44 20 3934 6630
Graham Herring
Zach Cohen
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDEAEDDEDFFEAA
(END) Dow Jones Newswires
March 04, 2021 02:00 ET (07:00 GMT)
Nanosynth (LSE:NNN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Nanosynth (LSE:NNN)
Historical Stock Chart
From Oct 2023 to Oct 2024